Inovio Pharma (INO) Misses Q2 EPS by 119c

Inovio Pharma (NASDAQ: INO) reported Q2 EPS of ($1.19). Revenue for the quarter came in at $100 thousand.

For earnings history and earnings-related data on Inovio Pharma (INO) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Indaptus Therapeutics (INDP) files for 59M share offering by selling stockholders
• Brookfield offers A$4.75/sh for Reliance Worldwide - Bloomberg